Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...
4don MSN
Antibodies' decoy tactics for outmaneuvering pathogens could inspire next-generation treatments
Pathogens can create sticky situations. When microbes invade the body to cause an infection, often one of their first lines ...
The rise of antibiotic resistance has renewed interest in bacteriophages as therapeutic alternatives. However, co-evolution of phage and bacteria will naturally give rise to phage-resistant pathogens, ...
Ferring Pharmaceuticals and Theralase® Technologies Inc. are pleased to announce that they have entered into a collaborative clinical development agreement ("Agreement") on January 9, 2026. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results